FDA
approval
· 2021-03-23
FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)
Summary
FDA approved a supplemental application for IMITREX (sumatriptan) submitted by GlaxoSmithKline LLC. The approval updates the product labeling or indication as d…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMITREX (SUMATRIPTAN)